Illustration of a vaccine vial and syringe.

Hope on the Horizon: New mRNA-based HIV Vaccine Trial Shows Promising Immune Response

A phase 1 clinical trial for a new type of preventative HIV vaccine using messenger RNA (mRNA) technology has yielded positive initial results, investigators report. The vaccine was found to be safe and generated a robust immune response in nearly all participants...

Read More
An illustration representing long-acting injectable treatments.

FDA Approves New Long-Acting Injectable ART, Offering Alternative to Daily Pills

The landscape of HIV treatment continues to evolve with the recent approval of a new long-acting injectable antiretroviral therapy. This new option, administered every two months, offers a significant quality-of-life improvement for people living with HIV who struggle with the burden of daily medication...

Read More
A depiction of gene editing technology.

Gene Therapy Breakthrough: Scientists Successfully Eliminate HIV from Genomes of Mice

In a landmark study, researchers have successfully used a CRISPR-based gene editing tool to remove all traces of the HIV virus from the genomes of infected mice. While this research is still in its early stages, it represents a significant step forward in the quest for a functional cure for HIV...

Read More